Applying Evidence-to-Decision Frameworks to Lifestyle Medicine in Viet Nam: Contextualization, Guideline Adaptation, and Clinical Governance

EVIDENCE & CLINICAL PRACTICERESEARCH & IMPLEMENTATION

11/22/202627 min read

Applying Evidence-to-Decision Frameworks to Lifestyle Medicine in Viet Nam: Contextualization, Guideline Adaptation, and Clinical Governance

Last reviewed: November 22, 2026

A Vietnamese healthcare organization identifies an international clinical guideline recommending a lifestyle intervention for patients with a chronic condition. The guideline comes from a recognized professional organization, draws on published research, and presents the intervention as part of evidence-based clinical care.

Introducing the recommendation into routine practice may initially seem straightforward. If the evidence is trustworthy and the intervention is beneficial, why not use it?

The question becomes more complicated when the clinical team considers how the recommendation would work locally. The intervention may require professional expertise that is not available in every facility. Patients may have different financial resources, working arrangements, dietary practices, or preferences from those represented in the original studies. Recommended monitoring arrangements may be difficult to provide, while existing Vietnamese clinical requirements may already govern important aspects of the proposed care.

These differences do not necessarily make the international recommendation inappropriate. They do, however, raise questions that cannot be answered by examining clinical effectiveness alone.

What benefits and harms can reasonably be expected for the intended patients? How certain is the evidence? Which outcomes matter most to them? What resources would implementation require? Could the intervention create additional barriers for disadvantaged groups? Who has the authority to decide whether and how the recommendation should be used?

These are the kinds of questions addressed by Evidence-to-Decision (EtD) frameworks.

For Lifestyle Medicine, such questions are particularly relevant because interventions involving nutrition, physical activity, sleep, and other health behaviors often require sustained participation, professional support, and adjustments to everyday routines.

An intervention may have convincing evidence of benefit while remaining difficult to deliver in a particular healthcare setting. At the same time, practical limitations should not become a reason to dismiss effective care without examining whether suitable alternatives or implementation arrangements are available.

The challenge is to connect scientific evidence with informed clinical and organizational decisions while maintaining a clear distinction between educational interpretation, formal guideline development, and the legal authority to provide healthcare services.

For Viet Nam, this offers a way to learn from international recommendations without assuming that their scientific credibility automatically establishes local feasibility, institutional approval, or regulatory authorization.

Why Scientific Evidence Does Not Automatically Determine a Recommendation

Clinical research helps establish what is known about the effects of an intervention. A systematic review may estimate whether a dietary intervention improves blood pressure, whether structured physical activity reduces symptoms, or whether a behavior-change program produces meaningful improvements in health outcomes.

Developing a recommendation, however, requires additional judgments. Evidence that an intervention provides a benefit does not automatically establish whether it should be offered to every eligible patient, which alternative should be preferred, or how strongly clinicians should recommend it.

Those decisions depend on the magnitude and certainty of expected benefits and harms, the importance of different outcomes, and the burden associated with treatment. Patient values, resource requirements, equity, acceptability, and feasibility may also influence the recommendation.

The GRADE Working Group has developed methods to make these judgments more systematic and transparent.

In June 2025, Guyatt and colleagues published Core GRADE 7: Principles for Moving From Evidence to Recommendations and Decisions in The BMJ.[1]

The paper explains how evidence can be translated into recommendations by examining the balance between desirable and undesirable consequences, the certainty of the evidence, and patients' values and preferences.

Within the Core GRADE approach, a strong recommendation is generally appropriate when the desirable consequences clearly outweigh the undesirable consequences, or the reverse. A conditional recommendation is more appropriate when that balance is less clear or when reasonable, well-informed patients may choose differently.

The certainty of evidence is important, but it is not the only consideration. An intervention supported by moderate-certainty evidence may still warrant a conditional recommendation when the expected benefit is modest, the intervention requires substantial effort, or patient preferences vary.

Conversely, an inexpensive and acceptable intervention does not automatically justify a strong recommendation if its clinical effectiveness remains uncertain. Strong recommendations based on low-certainty evidence are generally exceptional and require careful justification.

This distinction matters in Lifestyle Medicine because evidence supporting a healthy behavior is not necessarily equivalent to evidence supporting every intervention designed to promote that behavior.

For example, evidence that physical activity benefits health is not identical to evidence that a particular counseling program successfully increases physical activity or improves clinical outcomes. Similarly, research supporting healthier dietary patterns does not establish that every educational intervention intended to promote those patterns will produce equivalent benefits.

A guideline development group should therefore consider whether the available research directly addresses the population, intervention, comparator, and outcomes involved in the recommendation.

Confidence in the benefits of a healthy behavior should not automatically be transferred to the effectiveness of every program intended to promote it.

Structured Evidence-to-Decision methods help make this distinction visible. They clarify what the research demonstrates, where uncertainty remains, and which additional judgments are necessary before a recommendation can be justified.

What an Evidence-to-Decision Framework Adds

An Evidence-to-Decision framework provides a structured approach to examining the considerations that should inform a clinical recommendation or policy decision.

Rather than moving directly from selected research findings to a conclusion, it encourages decision-makers to document the relevant evidence, explain their judgments, and identify important uncertainties.

The GRADE Evidence-to-Decision approach addresses the priority of the problem, desirable and undesirable effects, certainty of evidence, patient values, the balance of effects, required resources, cost-effectiveness, equity, acceptability, and feasibility.

The importance and interpretation of these criteria depend on the decision being made.

A recommendation concerning an individual patient's treatment may place particular emphasis on expected benefits, harms, treatment burden, and personal preferences. A decision about introducing a program across several healthcare facilities may require broader consideration of workforce capacity, financial implications, and equitable access.

In June 2026, Meneses-Echavez and colleagues published Evidence-to-Decision Frameworks: Enhancing the Quality and Rigour of Guidelines and Recommendations in Clinical and Public Health Guidelines.[2]

The authors examined the development of EtD frameworks and their contribution to transparent, multidisciplinary recommendation development. They also discussed how some frameworks incorporate broader considerations, including human rights, social and cultural acceptability, environmental consequences, and sustainability.

These developments reflect a growing recognition that healthcare recommendations may have consequences extending beyond the immediate clinical effects of an intervention.

However, this does not mean that every recommendation should be evaluated against an identical set of criteria or that all considerations should receive equal weight. The relevant questions depend on the clinical issue, intended population, decision-making perspective, and purpose of the recommendation.

For Lifestyle Medicine, practical burden deserves particular attention. A structured program may require repeated appointments, specialist consultations, transportation expenses, changes to household routines, or substantial time commitments.

These demands do not necessarily outweigh the expected clinical benefits, but they can influence whether an intervention is acceptable and feasible for particular patients.

An EtD framework helps decision-makers consider such issues explicitly instead of treating them as secondary implementation problems.

Its value becomes particularly apparent when a recommendation involves difficult trade-offs. Different stakeholders may agree on the underlying evidence while reaching different conclusions about the most appropriate course of action.

A patient may consider an intervention worthwhile because it offers an opportunity to improve daily functioning. A healthcare organization may recognize the same potential benefit while questioning whether it can provide the necessary professional support consistently.

These perspectives are not necessarily contradictory. They reflect different considerations that should be examined together.

An EtD framework does not eliminate clinical judgment or turn recommendation development into a mechanical calculation. It makes the reasoning more transparent, consistent, and open to scrutiny.

Contextualization, Adoption, and Adaptation Serve Different Purposes

International clinical recommendations may be used in several ways, and the terminology matters.

Contextualization involves explaining how existing evidence or recommendations relate to a particular population, healthcare system, or institutional setting.

For example, an educational article may explain why an international Lifestyle Medicine recommendation is relevant to Vietnamese healthcare while identifying differences in food practices, professional roles, healthcare access, or local regulations.

Such an explanation can help clinicians interpret evidence without creating a new clinical guideline.

Adoption involves a more formal decision to accept an existing recommendation for use in a defined setting. The recommendation may remain unchanged, but the decision to use it should follow the appraisal, authorization, and implementation processes applicable to the organization.

A guideline does not become formally adopted simply because it has been translated, circulated, or discussed among healthcare professionals.

Guideline adaptation involves systematically assessing existing recommendations and their supporting evidence to determine whether those recommendations should be retained, modified, or reformulated for another context.

This may require reconsidering the intended population, available services, expected benefits and harms, patient values, resources, and implementation conditions.

De novo guideline development is different again. It involves developing recommendations through a structured process of identifying and reviewing evidence, making judgments, and formulating guidance rather than relying primarily on existing recommendations.

These approaches can overlap, and their precise boundaries may vary between methodological frameworks. The important requirement is to describe accurately what was undertaken.

A professional educational summary should not be presented as a formally adapted guideline. Likewise, preparing locally relevant teaching materials does not establish that a healthcare institution has approved a new treatment protocol.

Another distinction is necessary between developing a recommendation and implementing it.

A healthcare organization may conclude that an existing recommendation is scientifically appropriate without yet having the personnel, facilities, clinical procedures, or institutional authorization required to introduce the relevant service.

Formal adoption or adaptation should therefore not be confused with the operational and governance decisions necessary for clinical implementation.

For the Vietnam Lifestyle Medicine Alliance (VLMA), these distinctions are important.

Professional education and scientific knowledge exchange may involve explaining international recommendations, reviewing their evidence base, and identifying questions requiring local consideration.

Formal guideline development, institutional approval, and authorization of clinical activities are separate responsibilities. They require appropriate expertise, governance arrangements, and compliance with the applicable legal framework.

What Research Published in 2026 Reveals About Guideline Adaptation

Guideline adaptation has become an important area of evidence-based healthcare methodology.

Developing a trustworthy clinical guideline from the beginning can require substantial time, expertise, and financial resources. Using existing high-quality guidance may reduce unnecessary duplication, but adaptation does not remove the need for scientific appraisal and appropriate governance.

A scoping review by Zhu and colleagues, published in BMJ Evidence-Based Medicine in 2026, identified 49 approaches to clinical practice guideline adaptation and 151 documented applications.[3]

The review found considerable variation in how adaptation was defined and conducted. ADAPTE and GRADE-ADOLOPMENT were the most commonly used approaches among the applications examined.

The authors also identified gaps in the methodological steps addressed by existing approaches. Assessment of evidence certainty and procedures for establishing guideline development group processes were among the least consistently covered elements.

This matters because a process may appear systematic while leaving important judgments insufficiently documented.

Another study, Frameworks for Adaptation of Health Guidelines: A Systematic Survey Update, was published online in September 2026 in the Journal of Clinical Epidemiology.[4]

Darzi and colleagues identified 20 formal guideline adaptation frameworks, compared with eight identified in the earlier survey.

Of these, six were based on ADAPTE, three on GRADE-ADOLOPMENT, two combined elements of both approaches, and nine used other methodologies.

The identification of 20 frameworks does not contradict the 49 approaches reported by Zhu and colleagues. The two studies used different eligibility criteria and examined different bodies of methodological literature.

Darzi and colleagues focused on formal frameworks described in sufficient detail to permit reproducibility. Zhu and colleagues examined a broader range of adaptation approaches and documented applications.

The systematic survey also identified differences in the methodological emphasis of existing frameworks.

ADAPTE-based approaches generally provide a comprehensive process for reviewing and modifying source guidelines. GRADE-ADOLOPMENT-based approaches place greater emphasis on examining individual recommendations through Evidence-to-Decision judgments.

The authors identified recurring challenges, including the need for methodological expertise, substantial resources, trustworthy source guidelines, and the capacity to incorporate new evidence when necessary.

Together, these findings show that guideline adaptation can make more efficient use of existing scientific work, but it still requires a credible process.

Naming an internationally recognized framework does not establish that it was applied adequately.

The quality of an adapted recommendation depends on how the evidence was evaluated, how contextual differences were considered, how judgments were made, and how the work was governed and reported.

For healthcare organizations with limited methodological resources, these findings also highlight the importance of choosing a process that is appropriate to the scope and consequences of the proposed decision.

Choosing an Adaptation Method That Fits the Task

ADAPTE and GRADE-ADOLOPMENT are two influential approaches to guideline adaptation, but they are not interchangeable.

ADAPTE provides a structured methodology for adapting existing clinical practice guidelines to a different context.

The ADAPTE Collaboration's resource toolkit describes a process involving preparation, definition of scope and clinical questions, identification and appraisal of source guidelines, selection and customization of recommendations, external review, and planning for future updates.[5]

Its comprehensive approach is particularly relevant when an organization intends to review a substantial body of guidance and develop an adapted guideline addressing several related clinical questions.

However, the process requires time, coordination, and methodological expertise. It may be disproportionate when a healthcare organization needs to examine only one narrowly defined recommendation.

GRADE-ADOLOPMENT provides another approach.

Introduced by Schünemann and colleagues in 2017, GRADE-ADOLOPMENT combines GRADE Evidence-to-Decision methods with the adoption, adaptation, or de novo development of recommendations.[6]

Its recommendation-level focus allows a guideline development group to examine whether existing evidence and judgments remain appropriate in a new context.

A group may adopt a recommendation when the evidence, expected consequences, and relevant contextual considerations remain applicable.

It may adapt the recommendation when important differences justify changes in its wording, strength, or conditions of use.

Where existing recommendations or evidence are insufficient, additional evidence synthesis and the development of a new recommendation may be necessary.

Neither approach should be treated as universally superior.

The appropriate choice depends on the scope of the work, the quality of available guidance, the expertise of the development group, and the decisions that need to be made.

A hospital preparing a professional education resource does not necessarily need to undertake formal guideline adaptation. A healthcare organization intending to approve a clinical protocol, however, requires a process appropriate to that protocol's intended use and the applicable institutional and legal requirements.

Methodological terminology should reflect the work actually performed.

Calling a document GRADE-based does not establish that a complete GRADE process was conducted. Similarly, describing a document as an adapted guideline should be supported by a transparent account of the source recommendations, methods, judgments, and approval process.

The purpose of using an established framework is to improve the quality of decisions, not simply to create the appearance of scientific authority.

Appraising the Quality and Relevance of Existing Guidelines

An international guideline should not be selected solely because it was issued by a prominent professional organization.

The quality of its development process matters, as does the relevance of the supporting evidence to the intended clinical question.

A widely cited guideline may rely on an outdated evidence review. Another may contain useful recommendations but provide limited information about how uncertainty was assessed or conflicts of interest were managed.

Before formally adopting or adapting guidance, the responsible team should examine its scope, publication date, evidence base, methodology, and relevance to the intended population and healthcare setting.

The AGREE II instrument provides an established approach to appraising the methodological quality and reporting of clinical practice guidelines.[7]

Its six domains address scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, and editorial independence.

These domains can help identify strengths and limitations in the development process.

However, a favorable AGREE II assessment does not automatically establish that every recommendation is clinically correct or suitable for a particular patient population.

Appraisal of the overall guideline should be complemented by examination of the evidence and judgments supporting individual recommendations.

The currency of the evidence also matters.

An international guideline may have been developed using studies published several years earlier. New clinical trials, systematic reviews, safety information, or changes in standard care may affect the relevance of its conclusions.

The absence of a recent update does not automatically make a guideline invalid. It should, however, prompt consideration of whether important new evidence has emerged.

Different guidelines may also reach different conclusions about the same clinical topic.

Such differences can arise because they examine different populations, interventions, comparators, or outcomes. They may also reflect variation in evidence interpretation, patient values, or decision-making perspectives.

The appropriate response is not necessarily to choose the newest guideline or the one containing the strongest recommendation.

It is to understand why the recommendations differ and whether those differences matter for the intended patients and clinical setting.

When source guidelines disagree substantially, the development group should explain which guidance it considers most relevant and why.

Selecting recommendations from several documents without examining their underlying evidence and consistency can create a misleading impression that the resulting guidance has been systematically developed.

A trustworthy adaptation process must preserve the connection between each recommendation and the scientific reasoning supporting it.

Defining the Clinical Question and Understanding Patient Priorities

A useful Evidence-to-Decision process begins with a clearly defined clinical question.

A broad statement such as Lifestyle Medicine should be used in chronic disease management is insufficient for developing a specific clinical recommendation.

The relevant population, intervention, comparator, and outcomes need to be identified. The question should also describe the intended setting and whether particular patient groups require separate consideration.

A recommendation developed for relatively healthy adults may not apply in precisely the same way to people with advanced disease, significant functional limitations, or complex medication regimens.

Likewise, evidence from highly selected trial participants may not adequately represent patients with multiple chronic conditions who receive routine care.

These differences do not automatically require a completely new guideline, but they should prompt examination of whether the evidence remains sufficiently relevant.

Defining the question carefully also helps prevent unnecessary expansion of the work. A hospital evaluating one lifestyle-related clinical practice does not automatically need to develop a comprehensive guideline covering every Lifestyle Medicine domain.

Patient values and preferences are equally important.

Lifestyle Medicine recommendations often involve changes to everyday routines. These may affect food choices, work schedules, family arrangements, physical activity, and the time required for consultations or follow-up.

The expected clinical benefits may be meaningful, but patients can reasonably differ in how they value those benefits and the effort needed to obtain them.

A person living with several chronic conditions may place greater importance on maintaining independence and physical function than on a modest improvement in a laboratory measurement. Another may prioritize symptom relief, the ability to work, or avoiding additional treatment burden.

These priorities should not be assumed from the preferences of the guideline development group.

Where possible, evidence concerning patient values and preferences should be considered. Formal guideline development may also benefit from appropriate patient or public involvement.

Such involvement should be meaningful rather than symbolic. A single patient representative cannot be expected to reflect every perspective in a diverse population, but involving people affected by a recommendation may help identify important outcomes and practical concerns that professionals might otherwise overlook.

When patient preferences vary substantially, a conditional recommendation may be appropriate, with greater emphasis on shared decision-making.

For Vietnamese healthcare, these considerations are particularly relevant when interventions require sustained changes that may be difficult for some patients because of employment, financial, cultural, or family circumstances.

Patient-centered care does not mean setting aside scientific evidence. It means applying that evidence in a way that respects informed choices and recognizes the circumstances in which care is received.

Local Feasibility, Resources, and Equity

One important distinction in guideline adaptation is the difference between uncertainty about clinical effects and difficulty delivering an intervention locally.

Suppose a structured intervention has demonstrated benefit in well-designed studies but requires specialized personnel or facilities that are not consistently available.

The intervention may remain clinically effective under the conditions studied even if a particular healthcare organization cannot reproduce those conditions.

A lack of local resources should not automatically be interpreted as evidence that the intervention itself does not work.

Instead, it may affect whether implementation is feasible, whether the recommendation applies to the proposed local model, or whether another evidence-supported delivery approach should be considered.

These issues can interact. If the planned local intervention differs substantially from the intervention evaluated in research, concerns about the directness of the evidence may arise.

Nevertheless, operational limitations and evidence certainty should not be treated as interchangeable concepts.

The same distinction applies to costs.

An intervention may be affordable in one healthcare system but impose substantial financial or time burdens in another.

For Viet Nam, relevant considerations may include professional staffing, appointment availability, transportation, patient expenses, service capacity, and reimbursement arrangements.

International estimates of cost-effectiveness should not automatically be transferred to Vietnamese healthcare. Costs, financing arrangements, available alternatives, and patterns of service use may differ significantly.

An organization may therefore need local information about resource requirements even when the clinical evidence is strong.

Equity deserves similar attention.

A recommendation may be clinically reasonable but difficult for some patients to follow because of circumstances outside their immediate control.

People may have different access to nutritious food, safe environments for physical activity, appropriate healthcare services, and the time needed to participate in structured interventions.

A program requiring repeated in-person appointments may be manageable for someone living near a major hospital but difficult for a person with substantial travel requirements.

A digitally supported service may improve access for some patients while creating barriers for others with limited connectivity or digital literacy.

These differences affect who can receive an intervention and who is likely to benefit from it.

The 2025 Lifestyle Medicine Core Competencies explicitly recognize the importance of applying Lifestyle Medicine interventions in the context of social determinants of health.[16]

This provides further support for considering social and economic circumstances when translating international evidence into local practice.

An Evidence-to-Decision process should therefore examine whether implementing a recommendation could reduce or increase existing health inequalities.

Addressing equity may require adapting educational materials, modifying service arrangements, improving referral pathways, or providing additional support to patients facing greater barriers.

However, equity considerations do not justify unsupported claims about clinical effectiveness. Any proposed alternative intervention still needs to be assessed according to the evidence available for its expected benefits and harms.

Responsible contextualization seeks to preserve scientific integrity while addressing the conditions that influence access and practical implementation.

An Illustrative Vietnamese Example: Dietary Sodium Reduction in Hypertension Care

Consider a hypothetical outpatient department reviewing international recommendations concerning dietary sodium reduction for adults receiving care for hypertension.

The scientific rationale is well established. Reducing excessive dietary sodium can contribute to blood pressure management, and appropriate dietary interventions are included in evidence-based hypertension care.

The department's challenge is not simply to translate an international recommendation into Vietnamese. It needs to determine how the recommendation can be communicated and supported within its existing clinical services.

An Evidence-to-Decision approach would begin by defining the intended population and clinical question. The team would examine applicable Vietnamese clinical guidance, relevant international recommendations, and the evidence supporting them.

It would consider the expected benefits and potential harms or burdens of dietary changes, the certainty of the evidence, and whether particular patients require individualized nutritional management because of other medical conditions.

The team would also need to understand how patients obtain, prepare, and share food.

In Viet Nam, dietary sodium may come from several sources, including added salt, fish sauce, soy sauce, seasoning products, processed foods, and meals prepared outside the home.

Household eating practices can influence how practical a recommendation becomes. A person may understand the need to reduce sodium but have limited control over food prepared for a shared family meal.

These circumstances do not invalidate the underlying clinical evidence. They influence how dietary advice may need to be explained and supported.

The department might then consider whether its existing staff can provide appropriate counseling or whether referral to qualified nutrition professionals is necessary.

It could assess the availability of educational materials, consultation time, and suitable follow-up arrangements. Patients' preferences and financial circumstances may also influence which dietary changes are realistic.

Some elements of international guidance may remain suitable without modification, while locally relevant food examples and educational materials may improve understanding.

However, using familiar dietary examples does not independently establish that a new counseling intervention has been validated or that it will produce the same outcomes as interventions evaluated elsewhere.

If the department is preparing an educational resource for its clinicians, it should describe the work as contextualization or professional education.

If it intends to issue or revise a formal institutional clinical protocol, a different level of methodological review, authorization, and governance may be necessary.

The resulting protocol would also need to remain consistent with applicable Vietnamese clinical and technical guidance, authorized professional practice, and institutional requirements.

This example is hypothetical. It does not establish a new sodium-intake target, introduce a validated Vietnamese dietary intervention, or constitute an approved clinical protocol.

Its purpose is to illustrate how scientific evidence, patient circumstances, resource requirements, and governance can be considered together without overstating what has been established.

Clinical Governance and Professional Accountability

Formal guideline work involves responsibilities extending beyond reviewing scientific literature.

A trustworthy process requires clarity about who is making decisions, what expertise is needed, and how important judgments will be documented.

Depending on the subject, an appropriate development group may include relevant medical specialists, methodology experts, allied healthcare professionals, implementation specialists, and representatives of patients or other affected groups.

The composition should reflect the clinical question rather than follow a fixed organizational template.

A guideline involving nutritional treatment may require different professional expertise from one addressing physical activity in rehabilitation or behavioral support in primary care.

Conflicts of interest also need careful attention.

Financial relationships, professional commitments, and intellectual interests can influence how evidence is interpreted and which recommendations are favored.

Disclosure is an important starting point, but disclosure alone does not necessarily resolve a conflict.

Appropriate management may require restrictions on participation in certain decisions, independent review, or other safeguards proportionate to the circumstances.

The development group should also establish how disagreements will be addressed and how decisions will be recorded.

Consensus should not be mistaken for scientific certainty.

Experts may agree on a recommendation even when supporting evidence is limited. They may also disagree when evidence is relatively strong but the balance of benefits, burdens, and patient preferences remains difficult to judge.

A trustworthy process should explain the basis for important judgments and identify unresolved uncertainty where relevant.

External review can help identify missing evidence, unclear recommendations, implementation difficulties, or unintended consequences. However, it does not replace the formal approval processes applicable to the organization.

These governance considerations remain important regardless of whether the group uses ADAPTE, GRADE-ADOLOPMENT, or another recognized methodology.

A methodological framework can help structure the work. It does not confer clinical or regulatory authority on the people using it.

The responsible organization should also consider intellectual property requirements.

Translation, adaptation, or republication of substantial material from an international guideline may require permission or compliance with specific licensing conditions. Appropriate attribution and verification of reuse rights are particularly important when distributing translated documents, tables, figures, or other protected materials.

Scientific credibility, publication rights, and legal authorization are separate matters that should each be addressed.

Understanding the Vietnamese Regulatory Context

International clinical recommendations must be applied within Viet Nam's existing healthcare regulatory framework.

The Law on Medical Examination and Treatment No. 15/2023/QH15, as amended, provides the principal legal framework for regulated medical examination and treatment activities. Consolidated Document No. 26/VBHN-VPQH, issued by the Office of the National Assembly on February 26, 2026, provides a consolidated reference to the amended law.[10]

Government Decree No. 96/2023/NĐ-CP and Ministry of Health Circular No. 32/2023/TT-BYT, as amended, establish additional requirements within their respective scopes.[11,12]

Circular No. 25/2026/TT-BYT, issued on June 30, 2026, and effective August 15, 2026, amended selected provisions of several Ministry of Health circulars, including Circular No. 32/2023/TT-BYT.[13]

Within the applicable framework, healthcare activities must remain consistent with the facility's legally permitted professional activities and the lawful scope of practice of the professionals involved.

An international clinical guideline does not independently grant a healthcare facility permission to provide a regulated service or authorize a practitioner to perform activities outside their professional scope.

Similarly, an international Lifestyle Medicine qualification or certification does not automatically establish a new legally recognized medical specialty or expand practice authority in Viet Nam.

Healthcare organizations must distinguish between scientific recommendations, institutional clinical guidance, technical procedures, and legally applicable professional requirements.

A methodology such as GRADE-ADOLOPMENT may support the scientific development of a recommendation, but it does not replace the institutional or regulatory processes required for its intended clinical use.

The preventive healthcare framework is also relevant.

Viet Nam's Law on Disease Prevention No. 114/2025/QH15 became effective on July 1, 2026, together with relevant implementing regulations, including Government Decree No. 165/2026/NĐ-CP.[14,15]

These provisions provide an important context for disease prevention and activities addressing noncommunicable disease risk factors.

However, they should not be interpreted as establishing a separate regulatory approval pathway for adapting Lifestyle Medicine guidelines.

Where an organization intends to develop or implement clinical guidance, it needs to determine the applicable professional responsibilities, institutional authority, relevant national guidance, and approval procedures.

Data protection may also become relevant, particularly when guideline development involves collecting patient information, conducting research, or examining identifiable clinical records.

Viet Nam's Law on Personal Data Protection No. 91/2025/QH15 and Government Decree No. 356/2025/NĐ-CP have been effective since January 1, 2026.[17,18]

Their requirements must be considered according to the actual nature and purpose of the data-processing activities. Patient participation in a clinical service does not automatically authorize unrestricted secondary use or disclosure of identifiable information.

For VLMA, the appropriate role in this context is professional education, scientific knowledge exchange, and discussion of evidence-informed methods.

Publishing an educational analysis of international guidelines or Evidence-to-Decision frameworks does not constitute regulatory approval, institutional authorization, or official endorsement of a new clinical protocol.

Transparent Reporting and the RIGHT-Ad@pt Framework

A guideline adaptation process can produce a reasonable recommendation while leaving readers uncertain about how the decision was reached.

This makes it difficult for clinicians, patients, and other stakeholders to assess whether the recommendation is trustworthy.

Transparent reporting should identify the source guidelines, supporting evidence, methods used, judgments made, and reasons for important modifications. It should also explain how patient perspectives, resource requirements, equity considerations, and implementation conditions influenced the recommendation.

The RIGHT Statement, published in Annals of Internal Medicine in 2017, provides an established reporting framework for healthcare practice guidelines.[8]

It emphasizes clear reporting of recommendations, supporting evidence, development methods, funding, and other information necessary for readers to understand how the guideline was produced.

An additional resource is particularly relevant to adaptation.

The RIGHT-Ad@pt checklist, published by Song and colleagues in Annals of Internal Medicine in 2022, was developed specifically to improve reporting of adapted healthcare guidelines.[9]

It contains 34 items organized into seven sections covering basic information, scope, rigor of development, recommendations, external review and quality assurance, funding and management of interests, and other relevant information.

RIGHT-Ad@pt provides a focused reporting resource for adapted guidelines that may include recommendations adopted without modification, adapted for a new context, or developed de novo.

Its value lies in encouraging authors to explain not only what was recommended but also how existing recommendations were evaluated and why they were retained, modified, or replaced.

However, a reporting checklist does not independently establish that the underlying methodology was rigorous or that the recommendations are clinically appropriate.

A guideline may be reported clearly while still containing weaknesses in its evidence review or decision-making process.

Conversely, an otherwise reasonable recommendation may be difficult to evaluate when the supporting evidence and judgments are poorly documented.

For organizations using an EtD approach, a clear record of judgments is especially valuable.

It allows others to understand whether a recommendation was changed because of new evidence, differences in patient values, local resource limitations, equity concerns, or other factors.

These reasons should not be combined into a vague statement that the recommendation was modified to suit local circumstances.

Specific explanations improve transparency, support accountability, and make future updates more manageable.

Maintaining and Updating Recommendations

Clinical guidance should not be treated as permanently settled once it has been approved.

New evidence may change estimates of benefit or harm. Treatment options may evolve, while resources and services available within the healthcare system may also change.

A recommendation adapted for one setting may become less appropriate as circumstances develop.

Organizations should therefore establish responsibility for monitoring relevant developments and determining when review is needed.

An update process may consider newly published systematic reviews, important clinical trials, emerging safety information, changes in national guidance, or significant developments in service delivery.

Not every new study requires an immediate revision. Its importance depends on the quality and relevance of the evidence and whether the findings could materially change the recommendation.

Likewise, an operational difficulty does not always justify modifying the clinical recommendation itself.

A hospital may need to improve staffing, referral arrangements, educational materials, or follow-up procedures rather than alter an evidence-based recommendation.

The update process should distinguish changes in the scientific basis for a recommendation from changes in the organization's ability to implement it.

A clear review date, version history, and assigned responsibility can help professionals identify which guidance is current.

These arrangements are particularly important when recommendations are incorporated into electronic medical records, clinical decision-support systems, or digital educational materials.

An outdated recommendation may continue influencing care if electronic systems are not revised when the underlying guidance changes.

Responsible implementation therefore involves ongoing review, not simply initial publication or dissemination.

Using Evidence-to-Decision Methods Proportionately

Evidence-to-Decision frameworks are valuable, but they should not turn every routine clinical question into a formal guideline development project.

The level of methodological work should reflect the purpose, scope, and potential consequences of the decision.

A healthcare organization may need only an educational explanation of an established international recommendation. Another may need to determine whether a specific recommendation is suitable for formal adoption. An institution developing a comprehensive clinical guideline may require a more extensive process.

These activities should not be described as though they were equivalent.

A professional education article can explain supporting evidence, uncertainties, and relevant local considerations without claiming to establish a new recommendation.

A formal institutional guideline requires an appropriate development process, professional responsibility, transparent documentation, and the approvals required for its intended use.

A recommendation intended for national application may involve broader stakeholder participation, systematic evidence synthesis, assessment of population-level implications, and procedures applicable to the authorized body.

The appropriate starting point is to identify the decision that needs to be made.

For example, a hospital might first determine whether it needs a new clinical recommendation, an adaptation of existing guidance, or an improvement in how an already applicable recommendation is delivered.

These alternatives lead to different kinds of work.

Where an existing trustworthy recommendation is directly applicable, the organization may need to focus on implementation rather than undertake unnecessary guideline redevelopment.

Where important contextual differences affect the recommendation, a more structured adaptation process may be justified.

Where the evidence is inadequate or existing recommendations are unsuitable, additional evidence review or new recommendation development may be necessary.

Methods should be selected according to these needs rather than chosen merely because they are internationally recognized.

For Vietnamese healthcare organizations, a focused and transparent assessment of one important clinical recommendation may sometimes provide greater practical value than attempting to adapt an entire international guideline without sufficient expertise or resources.

The objective is to improve decision quality, preserve scientific integrity, and ensure that formal clinical use remains properly governed.

Strengthening Evidence-Informed Lifestyle Medicine Decisions in Viet Nam

International Lifestyle Medicine recommendations offer valuable resources for healthcare professionals in Viet Nam. They can help clinicians understand scientific developments, identify evidence-supported interventions, and learn from approaches used in other healthcare systems.

However, translating that knowledge into responsible local practice requires more than selecting a guideline and reproducing its recommendations.

Evidence-to-Decision frameworks provide a structured way to examine expected benefits, harms, uncertainty, patient values, resources, equity, and feasibility.

Guideline adaptation methods such as ADAPTE and GRADE-ADOLOPMENT offer approaches to using existing recommendations while considering the circumstances of another healthcare setting.

Methodological research published in 2026 demonstrates both the increasing use of these approaches and the continuing variation in how they are applied.

For Viet Nam, this reinforces the importance of distinguishing between explaining international guidance, formally adopting recommendations, adapting clinical guidelines, and developing new recommendations.

Each activity serves a different purpose, and formal clinical use must remain subject to applicable professional, institutional, and legal requirements.

For VLMA, the opportunity is to strengthen professional understanding of these distinctions through evidence-based education and scientific knowledge exchange.

This includes helping healthcare professionals recognize when international evidence is directly relevant, when contextual differences require further consideration, and what a trustworthy recommendation development process involves.

It also requires clarity about the limits of educational publications. Discussing an international methodology does not establish that VLMA has undertaken formal guideline adaptation or that its publications constitute approved clinical standards.

The value of Evidence-to-Decision methods lies in making important judgments more transparent and defensible.

A trustworthy recommendation is not simply one supported by an impressive list of studies. It is one whose expected benefits and harms have been examined carefully, whose uncertainties are understood, whose relevance to the intended population has been considered, and whose use is consistent with appropriate clinical governance.

In Lifestyle Medicine, where many interventions depend on sustained participation and the circumstances of everyday life, this level of reasoning is particularly important.

The central question is not only whether an intervention is supported by scientific evidence. It is whether the available evidence and relevant judgments justify recommending that intervention to the intended patients under the conditions in which it will actually be delivered.

That is how Evidence-to-Decision frameworks can contribute to more responsible, patient-centered, and evidence-based Lifestyle Medicine in Viet Nam.

References and Further Reading
  1. Guyatt G, Vandvik PO, Iorio A, et al. Core GRADE 7: Principles for Moving From Evidence to Recommendations and Decisions. BMJ. 2025;389:e083867. Published June 3, 2025. doi:10.1136/bmj-2024-083867.

  2. Meneses-Echavez JF, Alonso-Coello P, Vist G, Bracchiglione J, Song Y, Flottorp S, Rosenbaum SE. Evidence-to-Decision Frameworks: Enhancing the Quality and Rigour of Guidelines and Recommendations. Clinical and Public Health Guidelines. 2026;3(3):e70078. Published online June 5, 2026. doi:10.1002/gin2.70078.

  3. Zhu S, Wang R, Darzi AJ, et al. Current Knowledge on the Adaptation of Clinical Practice Guidelines: A Scoping Review. BMJ Evidence-Based Medicine. 2026;31(4):254–268. doi:10.1136/bmjebm-2025-113925.

  4. Darzi AJ, Torabiardakani K, El Hajj M, et al. Frameworks for Adaptation of Health Guidelines: A Systematic Survey Update. Journal of Clinical Epidemiology. 2026;200:112500. Published online September 9, 2026. doi:10.1016/j.jclinepi.2026.112500.

  5. The ADAPTE Collaboration. The ADAPTE Process: Resource Toolkit for Guideline Adaptation. Version 2.0. Guidelines International Network; 2009. Copyright 2010.

  6. Schünemann HJ, Wiercioch W, Brozek J, et al. GRADE Evidence to Decision (EtD) Frameworks for Adoption, Adaptation, and De Novo Development of Trustworthy Recommendations: GRADE-ADOLOPMENT. Journal of Clinical Epidemiology. 2017;81:101–110. doi:10.1016/j.jclinepi.2016.09.009.

  7. Brouwers MC, Kho ME, Browman GP, et al. AGREE II: Advancing Guideline Development, Reporting and Evaluation in Health Care. Canadian Medical Association Journal. 2010;182(18):E839–E842. doi:10.1503/cmaj.090449.

  8. Chen Y, Yang K, Marušic A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement. Annals of Internal Medicine. 2017;166(2):128–132. doi:10.7326/M16-1565.

  9. Song Y, Alonso-Coello P, Ballesteros M, et al. A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist. Annals of Internal Medicine. 2022;175(5):710–719. doi:10.7326/M21-4352.

  10. National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, dated January 9, 2023, as amended. Office of the National Assembly, Consolidated Document No. 26/VBHN-VPQH, February 26, 2026.

  11. Government of Viet Nam. Decree No. 96/2023/NĐ-CP, dated December 30, 2023, detailing selected provisions of the Law on Medical Examination and Treatment, as applicable.

  12. Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT, dated December 31, 2023, detailing selected provisions of the Law on Medical Examination and Treatment, as amended.

  13. Ministry of Health of Viet Nam. Circular No. 25/2026/TT-BYT, dated June 30, 2026, amending selected provisions of several Ministry of Health circulars, including Circular No. 32/2023/TT-BYT. Effective August 15, 2026.

  14. National Assembly of Viet Nam. Law on Disease Prevention No. 114/2025/QH15, dated December 10, 2025. Effective July 1, 2026.

  15. Government of Viet Nam. Decree No. 165/2026/NĐ-CP, dated May 15, 2026, detailing and guiding the implementation of selected provisions of the Law on Disease Prevention. Effective July 1, 2026.

  16. Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. Published online October 28, 2025. doi:10.1177/15598276251379821.

  17. National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15, dated June 26, 2025. Effective January 1, 2026.

  18. Government of Viet Nam. Decree No. 356/2025/NĐ-CP, dated December 31, 2025, detailing selected provisions and implementation measures of the Law on Personal Data Protection. Effective January 1, 2026.

Editorial, Clinical and Regulatory Note

This article is published by the Vietnam Lifestyle Medicine Alliance (VLMA) for professional education, scientific knowledge exchange, and discussion of evidence-informed approaches to interpreting and adapting international Lifestyle Medicine recommendations in Viet Nam.

It reviews selected international methodological frameworks, research findings, and relevant Vietnamese regulatory considerations. It is not a Vietnamese national clinical practice guideline, an officially adapted guideline, an approved treatment protocol, an accreditation standard, or an authoritative legal opinion.

The discussion of Evidence-to-Decision frameworks, ADAPTE, GRADE-ADOLOPMENT, AGREE II, RIGHT, and RIGHT-Ad@pt is intended to explain their purposes, principles, applications, and limitations. Their inclusion does not indicate that VLMA has completed a formal guideline adaptation process or issued an officially approved clinical recommendation.

Examples of guideline assessment, contextualization, adaptation, and clinical implementation are illustrative. They are not presented as completed VLMA projects, formally approved clinical protocols, or nationally applicable standards.

International clinical recommendations do not automatically acquire regulatory authority in Viet Nam. Their clinical use must remain consistent with applicable Vietnamese laws, relevant national clinical and technical guidance, institutional authorization, healthcare facility licensing, professional scopes of practice, and patient safety requirements.

Educational interpretation of a guideline must not be represented as formal guideline adoption or adaptation without an appropriate development and governance process.

Where guideline-related activities involve patient information, clinical research, or other regulated activities, responsible organizations must also comply with applicable confidentiality, personal-data protection, ethical, intellectual property, and institutional requirements.

International Lifestyle Medicine certification or membership in a professional organization does not independently authorize regulated clinical practice or expand professional scope under Vietnamese law.

VLMA does not independently authorize medical services, grant healthcare practice licenses, approve national treatment guidelines, certify institutional clinical protocols for regulatory purposes, or establish legally binding clinical recommendations through this article.

The scientific and regulatory materials referenced were reviewed through November 22, 2026. Organizations considering formal guideline adaptation or clinical implementation should verify current legal requirements, applicable clinical guidance, institutional responsibilities, and the methodological suitability of the proposed approach before proceeding.

Vietnam Lifestyle Medicine Alliance

Evidence-Based Lifestyle Medicine for Viet Nam.

Contact

contact@vlma.org

Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC

+84 909 228 476

+84 84 9999 911

© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.

A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.

VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.

VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.

VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.